期刊文献+

二参龙麦汤治疗冠心病不稳定型心绞痛30例临床观察

Clinical study on tho Treatment of unstable Angina Pectoris of coronarg Heart Disease With Ershenlonginai Decoction
下载PDF
导出
摘要 目的:观察自拟二参龙麦汤治疗冠心病不稳定型心绞痛临床疗效及对C反应蛋白的影响。方法:随机将60例冠心病不稳定型心绞痛患者分为治疗组和对照组。对照组采用常规西药治疗,治疗组在西药治疗基础上予以二参龙麦汤口服。观察两组治疗后心绞痛、心电图和中医证候疗效及C反应蛋白水平。结果:治疗组在心绞痛和中医证候疗效及改善C反应蛋白水平方面均明显优于对照组(P〈0.05或P〈0.01),心电图疗效和对照组差异无统计学意义(P〉0.05)。结论:二参龙麦汤配合常规西药治疗冠心病不稳定型心绞痛疗效显著,并可以有效改善治疗后C反应蛋白水平。这可能是其疗效机理之一。 Objective :To observe the effects of Ershenlongmai decoction on unstable angina pectoris of cororary heart disease and the influence of that on Creation protein. Methods: Sixty patients were randomly divided into treatment group and control group, the patienes in control group were treated with common western medicine, the one in treatment group were treated with Ershenlongmai decoction on the basis of therapy of control group, after treatment, the symptom of angina pectoris, electrocardiogram, therapeutic effect of TCM and the level of C reaction protein. Resalts : The treatment group was better than control group in the symptom of angina peetoris, therapeutic effect of TCM and the level of C reaction protein, without difference in electrocardiogram between of two groups, conclusion : Ershenlongmai decoction has distinct effect,can improve the level of C reaction Protein effectively, that may be the one of treatment mechanisms.
作者 李杰
出处 《医学信息(下旬刊)》 2010年第3期129-130,共2页 Medical information
关键词 冠心病不稳定型心绞痛 益气养阴活血法 二参龙麦汤 Vnsntable angina pectoris of coronary heart disease supplementing nourishing yin and promoting blood flow Ershenlongmai decoction
  • 相关文献

参考文献5

二级参考文献13

  • 1Pearson TA,Mensah GA,Alexander RW,et al.Markers of inflammation and cardiovascular disease:application to clinical and public health practice:a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association[J].Circulation,2003,107 (3):499 -511.
  • 2Pearson TA,Blair SN,Daniels SR,et al.American Heart Association guidelines for primary prevention of cardiovascular disease and stroke:2002 update:consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases.American Heart Association Science Advisory and Coordinating Committee[J].Circulation,2002,106 (3):388-391.
  • 3Hatanaka K,Li XA,Masnda K,et al.Immunohistochemical localization of C-reactive protein binding sites in human aortic lesions by a modified streptavidin biotinstaining method[J].Pathol Int,1995,45(7):631-641.
  • 4Rebuzzi AG,Quarante L,Liuzzo G,et al.Incremental prognostic value of serum levels of tropinin T and C-reactive protein on admission in parients with unstable angina pectoris[J].Am J Cardiol,1998,82(5):715-719.
  • 5Luc G, Bard J M, Arveiler D, et al. Lipoprotein (a) as a predictor of coronary heart disease: The PRIME Study. Atherosclerosis, 2001,163(2):377-384.
  • 6Seman L G, Deluca C, Jenner J L,et al. Lipoprotein (a)-cholesterol and coronary heart disease in the Framingham Heart Study. Clin Chem, 1999,45(7):1039-1046.
  • 7Lundstam U, Herlitz J, Karlsson T, et al. Serum lipids, lipoprtein (a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease. J Intern Med, 2002,251(2):111-118.
  • 8Marcovina S M, Hegele R A, Koschinsky M L. Lipoprotein (a) and coronary heart disease risk. Curr Cardiol Rep,1999,1(2):105-111.
  • 9Angles C E. Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process. Braz J Med Biol Res,1997,30(11):1271-1280.
  • 10Maeda S, Abe A, Seishima M, et al. Transient change of serum lipoprotein (a) as an acute phase protein. Atherosclerosis, 1989,78(1):145-150.

共引文献981

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部